Project Grant R01AI179743
- This $521,993 federal Project Grant award from the National Science Foundation's (NSF) Biological Sciences program (CFDA 47.074) supports research by North Carolina State University to determine the molecular mechanism by which the bacterial symbiont Cardinium causes cytoplasmic incompatibility in insects. The project aims to: Identify and study the Cardinium genes responsible for cytoplasmic incompatibility, including examining their localization, interaction with host proteins, and mutation...
- This Project Grant award from the National Science Foundation (NSF) Biological Sciences program (CFDA 47.074) supports research to investigate the mechanism of cytoplasmic incompatibility (CI) caused by the bacterial symbiont Cardinium hertigii in parasitic wasps. The $494,339 award, effective August 1, 2024 through July 31, 2028, aims to determine the molecular processes by which Cardinium sabotages host sperm, leading to embryonic death in uninfected female insects. The research will use the...
- This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $504,596 to Indiana University to conduct research on how the Wolbachia bacterium manipulates its insect host's biology to establish and maintain infection. The research aims to identify the molecular mechanisms, specifically the role of Wolbachia's ankyrin repeat proteins, that enable the bacterium to infect, persist,...
- This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research federal grant program (CFDA 93.855), provides $600,618 to The Pennsylvania State University (Penn State) to study the molecular mechanism of a male-killing gene in Wolbachia bacteria. The research aims to investigate how these maternally-inherited bacteria modify the reproductive biology of their host species to favor infected females, with a focus...
- This $198,724 Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859) supports research by the University of California, Santa Cruz on the functional genetic basis of the symbiotic relationship between the Wolbachia bacteria and Drosophila fruit flies. The overarching goal is to develop a robust understanding of the evolutionary genetics and functional mechanisms underlying this host-symbiont...
- This Project Grant award from the National Science Foundation's (NSF) Biological Sciences (CFDA 47.074) Federal Grant Program provides $384,104 to South Dakota State University (SDSU) to conduct collaborative research on the molecular mechanism by which the bacterial symbiont Cardinium hertigii causes cytoplasmic incompatibility (CI) in arthropod hosts. The research aims to better understand how this maternally-inherited bacterial symbiont sabotages host reproduction, with potential applications...
- The Department of Agriculture National Institute of Food and Agriculture awarded a $180,000 Project Grant to Regents Of The University Of Minnesota under the Agriculture and Food Research Initiative (AFRI) program. The University will conduct research on Wolbachia bacteria and its potential to manage arthropod pests as biological control agents. Using functional genomics, proteomics, and synthetic biology methods, the University will characterize Wolbachia proteins that may alter insect...
- This Project Grant award of $611,861 from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), supports research to investigate chromosomal rearrangements in the Aedes aegypti mosquito. The goal is to characterize the geographic distribution of chromosomal inversions in this mosquito species and determine their association with ecological variables and subspecies differentiation. The research will leverage...
- This Project Grant award of $211,038 from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) supports research at The Johns Hopkins University to investigate a new strategy for controlling mosquito populations. The key focus is on targeting the enzyme iodotyrosine deiodinase, which plays a critical role in protecting insects like fruit flies from the accumulation of harmful halotyrosines that can suppress...
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $302,537 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to Synvect, Inc. to finalize the development and commercialization of their NextGenSIT technology for Aedes aegypti mosquito control. The objectives of this grant are to: 1) finalize the genetic components for producing competitive, sterile male Ae. aegypti mosquitoes using CRISPR gene knockouts; 2) develop and validate...
THE EPIGENETICS OF CYTOPLASMIC INCOMPATIBILITY - PROJECT SUMMARY: WOLBACHIA ARE A GENUS OF ENDOSYMBIOTIC BACTERIA THAT COMPRISE A PROMISING, COST-EFFECTIVE TOOL TO CURB ARBOVIRAL TRANSMISSION BASED ON TWO KEY FACETS. FIRST, WOLBACHIA BLOCK PATHOGENIC RNA VIRUSES BY INHIBITING THEIR REPLICATION IN ARTHROPODS. SECOND, WOLBACHIA SELFISHLY ALTER SPERM AND EGG VIA A PROCESS TERMED CYTOPLASMIC INCOMPATIBILITY (CI) THAT CAN DRIVE THE BACTERIA INTO HOST POPULATIONS. CI IS EXPRESSED AS EMBRYONIC LETHALITY IN CROSSES BETWEEN INFECTED MALES AND UNINFECTED FEMALES, BUT THIS LETHALITY IS RESCUED IN CROSSES BETWEEN INFECTED MALES AND INFECTED FEMALES, WHICH ARE THE TRANSMITTING SEX OF WOLBACHIA. CONSEQUENTLY, CI IS DEPLOYED IN FIELD TRIALS TO EITHER SUPPRESS MOSQUITO POPULATION SIZES OR REPLACE UNINFECTED POPULATIONS WITH INFECTED INDIVIDUALS RESISTANT TO ARBOVIRAL INFECTION. WE RECENTLY DISCOVERED PRE-FERTILIZATION IMPAIRMENTS TO SPERM GENOME INTEGRITY THAT UNDERPIN THE CI DRIVE. THE CI-CAUSING CIF PROTEINS CIFA AND CIFB FROM A PROPHAGE REGION IN WMEL INTERACT WITH DEVELOPING SPERMATID NUCLEI TO ALTER THE EPIGENETICALLY-CONTROLLED, HISTONE-TO-PROTAMINE TRANSITION, NAMELY BY INCREASING HISTONE RETENTION IN DEVELOPING SPERMATIDS AND DECREASING PROTAMINE LEVELS IN THE MATURE SPERM. THE CIF PROTEINS DO NOT PATERNALLY TRANSFER TO THE FERTILIZED EMBRYOS, INSTEAD THE MODIFIED SPERM IN TESTES WITH IMPAIRED CHROMATIN INTEGRITY TRANSFERS TO BESTOW CI. DESPITE DECADES OF INTENSE RESEARCH AND CURRENT APPLICATIONS TO VECTOR CONTROL, THE MECHANISTIC DETAILS OF THESE PRE-FERTILIZATION IMPAIRMENTS REMAIN A CENTRAL ENIGMA AND ARE ONLY NOW SUBJECT TO INVESTIGATION. HERE, WE PROPOSE THE FIRST, IN-DEPTH EXAMINATION OF CI-DEFINING HISTONE MARKS AND PROTAMINE TYPES TO TEST THE CENTRAL HYPOTHESIS THAT THE CIF PROTEINS ALTER EPIGENETIC EVENTS DURING GAMETOGENESIS TO CAUSE CI AND RESCUE. IN AIM 1, WE WILL USE CUT & TAG CHROMATIN PROFILING TO DETERMINE CI- DEFINING, PRE-FERTILIZATION CHANGES IN SPERM HISTONE MODIFICATIONS CAUSING HISTONE RETENTION IN WMEL-INFECTED DROSOPHILA MELANOGASTER AND AEDES AEGYPTI. WE WILL ALSO TEST THE ESSENTIALITY OF THESE EPIGENETIC CHANGES TO CI BY CHEMICALLY INHIBITING HISTONE MODIFIER ENZYMES. IN AIM 2, WE WILL INVESTIGATE THE TYPE AND ABUNDANCE OF CI- DEFINING PROTAMINES THAT ARE DEPLETED IN MATURE SPERM. KNOCKOUT AND KNOCKDOWN TRANSGENIC EXPERIMENTS WILL LINK CI-DEFINING EMBRYONIC DEATH WITH THE NECESSITY OF SPECIFIC SPERM PROTAMINE GENES. FINALLY IN AIM 3, WE WILL EVALUATE RESCUE-DEFINING CHANGES IN THE GAMETIC CHROMATIN BY FIRST CHARACTERIZING MATERNAL CHANGES IN HISTONE TRANSCRIPTS AND PROTEIN ABUNDANCE DURING OOGENESIS. WE WILL THEN DETERMINE POST-FERTILIZATION EPIGENETIC CHANGES IN SPERM DNA THAT ORCHESTRATE PATERNAL CHROMATIN DECONDENSATION FOR EMBRYONIC VIABILITY. WE WILL ALSO VALIDATE THE ESSENTIALITY OF EPIGENETIC MODIFIERS TO RESCUE BY INHIBITING THEIR ENZYMATIC ACTIVITY. DESPITE THE RISING INTEREST IN DEPLOYING WOLBACHIA TO CURB ARBOVIRUS TRANSMISSION, STUDIES HAVE NOT YET YIELDED A REFINED, MOLECULAR BREAKTHROUGH UNCOVERING THE HOST EPIGENETICS DRIVING WOLBACHIA. IF SUCCESSFUL, THE PROPOSED RESEARCH WILL (I) REVEAL THE INCIPIENT, HOST EPIGENETIC EVENTS UNDERLYING THE CI DRIVE SYSTEM AT THE HEART OF VECTOR CONTROL STRATEGIES AND (II) PROVIDE A SIGNIFICANT GATEWAY TO EVENTUALLY ENGINEER CI AND RESCUE VIA THE HOST ARTHROPOD ITSELF.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $597.2k | 4/8/25 | ||
| Not listed | $47.3k | 9/4/24 | ||
| Not listed | $47.3k | 9/4/24 | ||
| Not listed | $705.1k | 5/7/24 | ||
| Not listed | $705.1k | 5/7/24 |